John F. Bedard

Mr. John F. Bedard has been Senior Vice President of Worldwide Regulatory Affairs at Mannkind Corp. since October 2005. Mr. Bedard has been engaged as a principal in a pharmaceutical consulting practice since 2002. Prior to that, he served in senior management positions during a 15-year career at Bristol-Myers Squibb and served as Vice President of FDA Liaison and Global Strategy. He has 25 years of experience, successfully directing development and registration programs in various therapeutic areas, including cardiovascular, metabolic, dermatology, gastroenterology and immunology. He served as Vice President, FDA Liaison & Global Strategy at Bristol- Myers Squibb (BMS) for over ten years. During that time, he directed the regulatory activities for a number of medically important programs. Prior to BMS, he served as Group Director of Regulatory Affairs at Smith Kline & French Laboratories from 1985 to 1988. From 1981 to 1985, he served as Regulatory Associate then Assistant Director of Regulatory Affairs. He served as Group Director of Regulatory Affairs at Ayerst Laboratories. Mr. Bedard has extensive experience working with the FDA, including ten FDA Advisory Panels for significant pharmaceutical product approvals. He has been Director of Synvista Therapeutics, Inc. since September 2007. He served as Director of Epicept Corporation from January 4, 2006 to February 3, 2009. He served as Director of Maxim Pharmaceuticals Inc. since October 2004. He also served as Director of Smith Kline & French Laboratories. Mr. Bedard graduated from Rutgers University with a B.A. in Chemistry. He received his M.S. from Saint Joseph’s University.